Literature DB >> 19528517

ABC/2 for rapid clinical estimate of infarct, perfusion, and mismatch volumes.

J R Sims1, L Rezai Gharai, P W Schaefer, M Vangel, E S Rosenthal, M H Lev, L H Schwamm.   

Abstract

BACKGROUND: Rapid and easy clinical assessments for volumes of infarction and perfusion mismatch are needed. We tested whether simple geometric models generated accurate estimates of these volumes.
METHODS: Acute diffusion-weighted image (DWI) and perfusion (mean transit time [MTT]) in 63 strokes and established infarct volumes in 50 subacute strokes were measured by computerized planimetry. Mismatch was defined as MTT/DWI > or = 1.2. Observers, blinded to planimetric values, measured lesions in three perpendicular axes A, B, and C. Geometric estimates of sphere, ellipsoid, bicone, and cylinder were compared to planimetric volume by least-squares linear regression.
RESULTS: The ABC/2 formula (ellipsoid) was superior to other geometries for estimating volume of DWI (slope 1.16, 95% confidence interval [CI] 0.94 to 1.38; R(2) = 0.91, p = 0.001) and MTT (slope 1.11, 95% CI 0.99 to 1.23; R(2) = 0.89, p = 0.001). The intrarater and interrater reliability for ABC/2 was high for both DWI (0.992 and 0.965) and MTT (0.881 and 0.712). For subacute infarct, the ABC/2 formula also best estimated planimetric volume (slope 1.00, 95% CI 0.98 to 1.19; R(2) = 0.74, p = 0.001). In general, sphere and cylinder geometries overestimated all volumes and bicone underestimated all volumes. The positive predictive value for mismatch was 92% and negative predictive value was 33%.
CONCLUSIONS: Of the models tested, ABC/2 is reproducible, is accurate, and provides the best simple geometric estimate of infarction and mean transit time volumes. ABC/2 has a high positive predictive value for identifying mismatch greater than 20% and might be a useful tool for rapid determination of acute stroke treatment.

Entities:  

Mesh:

Year:  2009        PMID: 19528517      PMCID: PMC2697964          DOI: 10.1212/WNL.0b013e3181aa5329

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  31 in total

1.  Impact of diffusion-weighted MRI-measured initial cerebral infarction volume on clinical outcome in acute stroke patients with middle cerebral artery occlusion treated by thrombolysis.

Authors:  Daniel Sanák; Vladimír Nosál'; David Horák; Andrea Bártková; Kamil Zelenák; Roman Herzig; Jirí Bucil; David Skoloudík; Stanislav Burval; Viera Cisariková; Ivanka Vlachová; Martin Köcher; Jana Zapletalová; Egon Kurca; Petr Kanovský
Journal:  Neuroradiology       Date:  2006-08-29       Impact factor: 2.804

2.  Comparison of ABC/2 estimation technique to computer-assisted planimetric analysis in warfarin-related intracerebral parenchymal hemorrhage.

Authors:  Hagen B Huttner; Thorsten Steiner; Marius Hartmann; Martin Köhrmann; Eric Juettler; Stephan Mueller; Johannes Wikner; Uta Meyding-Lamade; Peter Schramm; Stefan Schwab; Peter D Schellinger
Journal:  Stroke       Date:  2005-12-22       Impact factor: 7.914

3.  Evaluation of early computed tomographic findings in acute ischemic stroke.

Authors:  M P Marks; E B Holmgren; A J Fox; S Patel; R von Kummer; J Froehlich
Journal:  Stroke       Date:  1999-02       Impact factor: 7.914

4.  Lack of clinical significance of early ischemic changes on computed tomography in acute stroke.

Authors:  S C Patel; S R Levine; B C Tilley; J C Grotta; M Lu; M Frankel; E C Haley; T G Brott; J P Broderick; S Horowitz; P D Lyden; C A Lewandowski; J R Marler; K M Welch
Journal:  JAMA       Date:  2001-12-12       Impact factor: 56.272

Review 5.  The evolving role of acute stroke imaging in intravenous thrombolytic therapy: patient selection and outcomes assessment.

Authors:  John Sims; Lee H Schwamm
Journal:  Neuroimaging Clin N Am       Date:  2005-05       Impact factor: 2.264

6.  The Desmoteplase in Acute Ischemic Stroke Trial (DIAS): a phase II MRI-based 9-hour window acute stroke thrombolysis trial with intravenous desmoteplase.

Authors:  Werner Hacke; Greg Albers; Yasir Al-Rawi; Julien Bogousslavsky; Antonio Davalos; Michael Eliasziw; Michael Fischer; Anthony Furlan; Markku Kaste; Kennedy R Lees; Mariola Soehngen; Steven Warach
Journal:  Stroke       Date:  2004-11-29       Impact factor: 7.914

7.  Shape and volume of lacunar infarcts: a 3D MRI study in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy.

Authors:  Dominique Hervé; Jean-François Mangin; Nicolas Molko; Marie-Germaine Bousser; Hugues Chabriat
Journal:  Stroke       Date:  2005-10-13       Impact factor: 7.914

8.  Effects of alteplase beyond 3 h after stroke in the Echoplanar Imaging Thrombolytic Evaluation Trial (EPITHET): a placebo-controlled randomised trial.

Authors:  Stephen M Davis; Geoffrey A Donnan; Mark W Parsons; Christopher Levi; Kenneth S Butcher; Andre Peeters; P Alan Barber; Christopher Bladin; Deidre A De Silva; Graham Byrnes; Jonathan B Chalk; John N Fink; Thomas E Kimber; David Schultz; Peter J Hand; Judith Frayne; Graeme Hankey; Keith Muir; Richard Gerraty; Brian M Tress; Patricia M Desmond
Journal:  Lancet Neurol       Date:  2008-02-28       Impact factor: 44.182

9.  MR diffusion-weighted imaging and outcome prediction after ischemic stroke.

Authors:  P J Hand; J M Wardlaw; C S Rivers; P A Armitage; M E Bastin; R I Lindley; M S Dennis
Journal:  Neurology       Date:  2006-03-08       Impact factor: 9.910

10.  Clinical-diffusion mismatch defined by NIHSS and ASPECTS in non-lacunar anterior circulation infarction.

Authors:  H Tei; S Uchiyama; T Usui
Journal:  J Neurol       Date:  2007-03-07       Impact factor: 4.849

View more
  154 in total

1.  Acute administration of tirofiban versus aspirin in emergent carotid artery stenting.

Authors:  Philipp Gruber; Martin Hlavica; Jatta Berberat; Benjamin Victor Ineichen; Michael Diepers; Krassen Nedeltchev; Timo Kahles; Luca Remonda
Journal:  Interv Neuroradiol       Date:  2018-11-04       Impact factor: 1.610

2.  Serum CXCL12 Levels as a Novel Predictor of Future Stroke Recurrence in Patients with Acute Ischemic Stroke.

Authors:  Xiao-Lin Gu; Lin Liu; Xiang-Dong Lu; Zhen-Rui Liu
Journal:  Mol Neurobiol       Date:  2015-04-02       Impact factor: 5.590

3.  Association of serum 25-hydroxyvitamin D with symptoms of depression after 6 months in stroke patients.

Authors:  Wei Yue; Lei Xiang; Ya-Jing Zhang; Yong Ji; Xin Li
Journal:  Neurochem Res       Date:  2014-08-26       Impact factor: 3.996

4.  Outcomes in severe middle cerebral artery ischemic stroke.

Authors:  Brian P Walcott; Jennifer C Miller; Churl-Su Kwon; Sameer A Sheth; Marc Hiller; Carolyn A Cronin; Lee H Schwamm; J Marc Simard; Kristopher T Kahle; W Taylor Kimberly; Kevin N Sheth
Journal:  Neurocrit Care       Date:  2014-08       Impact factor: 3.210

5.  Serum levels of homocysteine at admission are associated with post-stroke depression in acute ischemic stroke.

Authors:  Yan Li; Li-Li Cao; Lin Liu; Qin-De Qi
Journal:  Neurol Sci       Date:  2017-02-18       Impact factor: 3.307

6.  High Free Fatty Acid Levels Are Associated with Stroke Recurrence and Poor Functional Outcome in Chinese Patients with Ischemic Stroke.

Authors:  Z Niu; H Hu; F Tang
Journal:  J Nutr Health Aging       Date:  2017       Impact factor: 4.075

7.  Elevated Serum Levels of Neopterin at Admission Predicts Depression After Acute Ischemic Stroke: a 6-Month Follow-Up Study.

Authors:  Chao-Zhi Tang; Yu-Ling Zhang; Wen-Sheng Wang; Wei-Guo Li; Ji-Peng Shi
Journal:  Mol Neurobiol       Date:  2015-06-04       Impact factor: 5.590

8.  Neopterin as a Predictor of Functional Outcome and Mortality in Chinese Patients with Acute Ischemic Stroke.

Authors:  Xianwei Zeng; Guoqing Zhang; Bin Yang; Bo Zhang; Linpeng Zhang; Ying Ni; Chen Liu; Yumeng Luo
Journal:  Mol Neurobiol       Date:  2015-07-15       Impact factor: 5.590

9.  Decreased Concentration of Irisin Is Associated with Poor Functional Outcome in Ischemic Stroke.

Authors:  Wen-Jun Tu; Han-Cheng Qiu; Jian-Lei Cao; Qiang Liu; Xian-Wei Zeng; Ji-Zong Zhao
Journal:  Neurotherapeutics       Date:  2018-10       Impact factor: 7.620

Review 10.  Use of magnetic resonance imaging to predict outcome after stroke: a review of experimental and clinical evidence.

Authors:  Tracy D Farr; Susanne Wegener
Journal:  J Cereb Blood Flow Metab       Date:  2010-01-20       Impact factor: 6.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.